EDIT

WEEKLY STOCK MARKET DIGEST: STOCK MARKET REACHES TACTICAL PROFIT TAKING ZONE, POWELL’S FAVORITE INDICATOR PROVIDES NO RELIEF

By Nigam Arora & Dr. Natasha Arora Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules

Read More

STOCK BUYING ON HOPE STRATEGY AHEAD OF KEY EARNINGS, THE FED AND GDP

By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Pivotal Week Please click here for a chart of S&P 500 ETF (SPY) which represents the benchmark stock market index S&P 500 (SPX). Note the following: The chart compares S&P 500 ETF SPY with Nasdaq

Read More

VERY NICE GAINS ON GENE EDITING COMPANY EDITAS MEDICINE — TAKE PARTIAL PROFITS

This is the golden age of gene editing.  Our view of gene editing company  Editas Medicine (EDIT) is positive but a stock and a company are two different things. This stock has been highly pumped recently. This provided a trading opportunity from the short side.  The stock was sold short

Read More

Do you want to gain an edge in the markets? Join thousands of your fellow investors and money managers to subscribe to Generate Wealth newsletter.

 

FREE FOREVER

Follow The Most Accurate Stock Market Analysis

Unrivaled Insights
In Bull and Bear Markets

Generate Wealth Newsletter
Free Forever

Generate Wealth Newsletter
Free Forever